NPI: 1689282147 · ELIZABETHTOWN, KY 42701 · General Acute Care Hospital · NPI assigned 07/21/2020
Authorized official CARRICO, RICHARD controls 20+ related entities in our dataset. Read more
| Authorized Official | CARRICO, RICHARD (CHIEF FINANCIAL OFFICER) |
| NPI Enumeration Date | 07/21/2020 |
Other providers sharing the same authorized official: CARRICO, RICHARD
| Year | Claims | Total Paid |
|---|---|---|
| 2020 | 547 | $10.89 |
| 2021 | 431,649 | $23.27M |
| 2022 | 472,267 | $23.93M |
| 2023 | 506,179 | $24.76M |
| 2024 | 408,992 | $23.64M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 51,617 | 43,707 | $12.11M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 11,752 | 10,346 | $7.45M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 21,484 | 17,719 | $6.14M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8,860 | 7,301 | $3.18M |
| 70450 | Computed tomography, head or brain; without contrast material | 7,455 | 6,150 | $2.19M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3,529 | 3,115 | $1.95M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 4,173 | 2,962 | $1.93M |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 3,421 | 1,419 | $1.85M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 11,335 | 10,146 | $1.61M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 38,217 | 20,531 | $1.49M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 11,565 | 5,514 | $1.41M |
| 96375 | Therapeutic injection; each additional sequential IV push | 20,243 | 15,181 | $1.41M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2,507 | 2,232 | $1.34M |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 1,112 | 828 | $1.30M |
| 41899 | Unlisted procedure, dentoalveolar structures | 537 | 511 | $1.30M |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 2,622 | 1,366 | $1.20M |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 3,746 | 3,025 | $1.18M |
| 80053 | Comprehensive metabolic panel | 121,801 | 83,170 | $1.17M |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 24,305 | 17,818 | $1.09M |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 1,896 | 1,430 | $1.05M |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 16,842 | 14,993 | $1.05M |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 2,217 | 1,765 | $993K |
| 71045 | Radiologic examination, chest; single view | 23,299 | 17,621 | $951K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 1,403 | 1,170 | $917K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 19,994 | 11,516 | $914K |
| G0378 | Hospital observation service, per hour | 1,637 | 1,387 | $834K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 1,947 | 1,764 | $832K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1,655 | 1,308 | $806K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 2,167 | 1,969 | $786K |
| 36415 | Collection of venous blood by venipuncture | 165,355 | 79,140 | $748K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 6,186 | 5,931 | $727K |
| 74178 | 773 | 628 | $717K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 11,358 | 6,926 | $709K |
| 59025 | Fetal non-stress test | 5,099 | 2,708 | $668K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 6,212 | 5,403 | $627K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 96,567 | 78,191 | $615K |
| 71250 | 3,111 | 2,660 | $566K | |
| J2785 | Injection, regadenoson, 0.1 mg | 784 | 706 | $529K |
| 73221 | 1,273 | 1,164 | $494K | |
| 93017 | 1,440 | 1,333 | $475K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 9,743 | 8,555 | $475K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 453 | 402 | $458K |
| 84443 | Thyroid stimulating hormone (TSH) | 33,541 | 30,532 | $451K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 4,006 | 3,654 | $446K |
| 72141 | 1,163 | 1,032 | $437K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 1,465 | 1,279 | $435K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 1,222 | 1,051 | $425K |
| 78815 | Positron emission tomography (PET) for limited area imaging | 674 | 468 | $421K |
| 76830 | Ultrasound, transvaginal | 3,364 | 3,101 | $412K |
| 73562 | 3,314 | 2,893 | $390K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 19,687 | 14,541 | $381K |
| 96361 | Intravenous infusion, hydration; each additional hour | 6,543 | 4,283 | $378K |
| 80061 | Lipid panel | 33,250 | 29,100 | $377K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 8,954 | 8,256 | $366K |
| 83880 | 11,230 | 9,690 | $362K | |
| 93971 | 1,582 | 1,447 | $361K | |
| 73630 | 2,760 | 2,474 | $358K | |
| 72100 | 3,312 | 2,910 | $349K | |
| 73030 | 3,376 | 2,789 | $348K | |
| 71046 | Radiologic examination, chest; 2 views | 7,746 | 6,754 | $342K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 10,899 | 10,112 | $325K |
| 74018 | 3,391 | 3,024 | $325K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 6,275 | 5,365 | $319K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 10,823 | 10,092 | $312K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 13,055 | 11,866 | $311K |
| 73130 | 2,358 | 2,026 | $303K | |
| 73610 | 2,437 | 2,162 | $298K | |
| 76642 | 2,344 | 2,175 | $296K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 20,433 | 15,556 | $294K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 2,152 | 1,222 | $282K |
| 76775 | 1,217 | 1,107 | $276K | |
| 70486 | 849 | 770 | $269K | |
| 72110 | 1,320 | 1,103 | $261K | |
| 96376 | 3,858 | 2,593 | $246K | |
| 72050 | 1,527 | 1,288 | $239K | |
| 73110 | 1,718 | 1,432 | $229K | |
| 84702 | 17,717 | 14,908 | $219K | |
| 76536 | 1,799 | 1,656 | $219K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 8,524 | 7,539 | $218K |
| 80050 | General health panel | 6,304 | 5,535 | $215K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1,585 | 1,385 | $204K |
| J3490 | Unclassified drugs | 2,088 | 1,678 | $203K |
| 96367 | 2,187 | 849 | $202K | |
| 47562 | 144 | 90 | $200K | |
| 94060 | 1,601 | 1,236 | $199K | |
| 84484 | 18,883 | 12,712 | $198K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 3,893 | 1,155 | $194K |
| C1769 | Guide wire | 1,528 | 1,198 | $194K |
| 72072 | 1,421 | 1,220 | $191K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,702 | 1,029 | $189K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 320 | 290 | $188K |
| C1776 | Joint device (implantable) | 124 | 39 | $188K |
| 87480 | 9,006 | 8,040 | $174K | |
| 77066 | Tomosynthesis, mammo | 1,662 | 1,311 | $170K |
| 73502 | 2,116 | 1,686 | $168K | |
| 74022 | 938 | 872 | $167K | |
| 70491 | 473 | 378 | $162K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 21,884 | 20,077 | $157K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 3,676 | 3,174 | $157K |
| C1889 | Implantable/insertable device, not otherwise classified | 1,473 | 1,018 | $150K |
| 74183 | 364 | 303 | $146K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 19,712 | 17,454 | $145K |
| 84439 | 19,020 | 17,145 | $144K | |
| 87660 | 8,500 | 7,938 | $143K | |
| 87510 | 8,501 | 7,939 | $141K | |
| 82607 | 11,476 | 10,243 | $141K | |
| 83690 | 24,721 | 21,501 | $140K | |
| 47563 | 196 | 92 | $138K | |
| 71271 | 1,637 | 1,486 | $131K | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 805 | 574 | $131K |
| 95806 | 650 | 602 | $129K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1,030 | 980 | $128K |
| 95886 | 316 | 280 | $127K | |
| 78264 | 237 | 170 | $126K | |
| 87506 | 609 | 578 | $125K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 145 | 131 | $124K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 8,715 | 8,292 | $120K |
| 74019 | 1,219 | 1,129 | $118K | |
| 87081 | 18,023 | 16,815 | $117K | |
| 86803 | 9,665 | 8,969 | $115K | |
| 72040 | 826 | 706 | $114K | |
| 77065 | Tomosynthesis, mammo | 1,381 | 1,044 | $113K |
| 84466 | 10,988 | 9,988 | $113K | |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 3,085 | 2,885 | $112K |
| 58661 | 113 | 100 | $109K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 3,543 | 3,313 | $105K |
| 82746 | 8,719 | 8,064 | $102K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 4,795 | 1,705 | $101K |
| 93880 | 521 | 469 | $101K | |
| 78227 | 174 | 144 | $98K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 5,410 | 3,761 | $98K |
| 82728 | 8,492 | 7,513 | $96K | |
| 83735 | 16,986 | 13,276 | $96K | |
| 80074 | 2,950 | 2,536 | $95K | |
| C1781 | Mesh (implantable) | 124 | 99 | $95K |
| 95816 | 235 | 222 | $94K | |
| 73590 | 838 | 730 | $94K | |
| 71101 | 773 | 621 | $93K | |
| J7050 | Infusion, normal saline solution, 250 cc | 3,813 | 1,266 | $93K |
| 73560 | 929 | 793 | $93K | |
| 97161 | 3,066 | 1,738 | $92K | |
| 76870 | 795 | 716 | $91K | |
| 73090 | 798 | 676 | $91K | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 979 | 862 | $90K |
| 77080 | 1,615 | 1,235 | $88K | |
| 88304 | 2,450 | 1,971 | $86K | |
| J2704 | Injection, propofol, 10 mg | 17,222 | 13,515 | $83K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 7,348 | 6,359 | $81K |
| 82077 | 6,091 | 4,899 | $81K | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 984 | 855 | $80K |
| 94726 | 1,329 | 1,227 | $79K | |
| 70498 | 280 | 235 | $79K | |
| 70496 | 236 | 195 | $79K | |
| 88307 | 841 | 575 | $78K | |
| 73080 | 763 | 649 | $77K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 872 | 746 | $76K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1,272 | 447 | $76K |
| 12001 | 621 | 538 | $75K | |
| 96415 | 332 | 239 | $72K | |
| 88142 | 3,906 | 3,711 | $72K | |
| G0432 | Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening | 4,747 | 4,186 | $70K |
| G0330 | Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room | 28 | 28 | $67K |
| 81001 | 24,181 | 20,345 | $66K | |
| 86003 | 1,130 | 1,009 | $65K | |
| 80143 | 4,116 | 3,568 | $65K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 8,932 | 6,127 | $64K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 150 | 143 | $62K |
| 94729 | 1,204 | 1,162 | $62K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 56 | 54 | $62K |
| 83540 | 11,649 | 10,554 | $62K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 158 | 153 | $61K |
| 80179 | 4,083 | 3,563 | $59K | |
| 83605 | 6,187 | 4,852 | $57K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1,905 | 675 | $56K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 6,820 | 6,106 | $53K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 827 | 742 | $53K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1,960 | 1,844 | $52K |
| 87040 | 6,094 | 3,284 | $52K | |
| 82948 | 8,158 | 4,168 | $52K | |
| 82805 | 879 | 745 | $52K | |
| 97535 | Self-care/home management training, each 15 minutes | 1,614 | 932 | $51K |
| 10060 | 153 | 121 | $51K | |
| 88342 | 1,088 | 795 | $50K | |
| 85027 | 9,172 | 7,914 | $50K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 380 | 340 | $49K |
| 87186 | 6,782 | 5,933 | $49K | |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 691 | 649 | $47K |
| 87522 | Neg quan hep c or qual rna | 1,411 | 1,235 | $47K |
| 77336 | 430 | 80 | $42K | |
| 84403 | 2,017 | 1,812 | $42K | |
| 64447 | 30 | 26 | $41K | |
| 87070 | 5,748 | 4,218 | $40K | |
| 95811 | 29 | 26 | $40K | |
| 36591 | 1,833 | 704 | $40K | |
| 83013 | 689 | 639 | $38K | |
| 76801 | 363 | 335 | $38K | |
| 87077 | 5,451 | 4,314 | $38K | |
| 97165 | 1,011 | 782 | $38K | |
| 76000 | 385 | 324 | $37K | |
| 80055 | 706 | 633 | $37K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 8,802 | 6,590 | $37K |
| 86850 | 4,031 | 3,410 | $35K | |
| 91200 | 330 | 302 | $35K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 190 | 129 | $34K |
| 73140 | 394 | 340 | $34K | |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | 2,258 | 2,147 | $33K |
| J7120 | Ringers lactate infusion, up to 1000 cc | 6,377 | 5,376 | $32K |
| C1726 | Catheter, balloon dilatation, non-vascular | 165 | 133 | $32K |
| J7030 | Infusion, normal saline solution , 1000 cc | 8,749 | 5,647 | $32K |
| 82962 | 8,326 | 4,227 | $32K | |
| 85610 | 8,877 | 7,000 | $32K | |
| 76770 | 165 | 126 | $31K | |
| 76942 | 274 | 226 | $31K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 3,569 | 2,028 | $31K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 587 | 492 | $30K |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 137 | 128 | $30K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 273 | 260 | $30K |
| 81003 | 14,477 | 12,957 | $30K | |
| 86038 | 2,893 | 2,586 | $29K | |
| C2617 | Stent, non-coronary, temporary, without delivery system | 444 | 382 | $29K |
| 82784 | 1,865 | 1,612 | $29K | |
| 84112 | 355 | 303 | $29K | |
| 84146 | 1,770 | 1,565 | $28K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 85 | 78 | $28K |
| 83970 | 893 | 753 | $28K | |
| 82043 | 5,788 | 5,267 | $28K | |
| C9776 | Intraoperative near-infrared fluorescence imaging of major extra-hepatic bile duct(s) (e.g., cystic duct, common bile duct and common hepatic duct) with intravenous administration of indocyanine green (icg) (list separately in addition to code for primary procedure) | 32 | 27 | $27K |
| 87147 | 3,088 | 2,064 | $27K | |
| 0001A | 890 | 849 | $27K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 21,239 | 17,978 | $26K |
| 90715 | 779 | 736 | $26K | |
| 0002A | 811 | 776 | $25K | |
| 82550 | 4,471 | 3,816 | $25K | |
| 87807 | 2,242 | 2,120 | $25K | |
| 81025 | 3,934 | 3,460 | $25K | |
| 36430 | 49 | 37 | $25K | |
| 83001 | 1,604 | 1,448 | $25K | |
| 82570 | 5,773 | 5,087 | $25K | |
| 87653 | 761 | 735 | $25K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 738 | 294 | $24K |
| 12011 | 213 | 199 | $24K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 69 | 67 | $24K |
| 84402 | 1,141 | 1,034 | $24K | |
| 87493 | 1,170 | 1,046 | $24K | |
| 86480 | 459 | 428 | $24K | |
| 87088 | 3,604 | 3,128 | $23K | |
| 82274 | 1,717 | 1,377 | $23K | |
| 84481 | 1,644 | 1,531 | $22K | |
| 82553 | 2,533 | 2,288 | $22K | |
| 87505 | 230 | 192 | $21K | |
| 87340 | 2,520 | 2,307 | $21K | |
| 86696 | 1,325 | 1,094 | $21K | |
| 12002 | 153 | 146 | $21K | |
| 87800 | 615 | 515 | $20K | |
| 86780 | 1,815 | 1,622 | $20K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 154 | 142 | $20K |
| 86140 | 4,462 | 3,820 | $19K | |
| 95911 | 34 | 28 | $19K | |
| 74420 | 42 | 37 | $19K | |
| 86665 | 696 | 584 | $18K | |
| 86235 | 251 | 190 | $18K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 883 | 788 | $18K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 4,288 | 3,537 | $17K |
| 83002 | 1,151 | 1,036 | $17K | |
| 86225 | 1,566 | 1,359 | $17K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 2,520 | 2,140 | $16K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 326 | 300 | $16K |
| 85379 | 1,929 | 1,790 | $16K | |
| 85730 | 3,636 | 3,065 | $16K | |
| 86677 | 684 | 635 | $16K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 13,707 | 11,538 | $16K |
| 72146 | 40 | 31 | $15K | |
| 86695 | 1,224 | 1,080 | $15K | |
| 78226 | 37 | 27 | $15K | |
| 64721 | 36 | 16 | $15K | |
| 86376 | 1,254 | 1,122 | $14K | |
| 76999 | 195 | 142 | $14K | |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | 211 | 93 | $14K |
| 96417 | 118 | 79 | $14K | |
| 82785 | 926 | 826 | $14K | |
| 84703 | 2,211 | 2,012 | $13K | |
| 86901 | 4,461 | 3,918 | $13K | |
| 86900 | 4,315 | 3,770 | $13K | |
| J1756 | Injection, iron sucrose, 1 mg | 137 | 55 | $13K |
| C1758 | Catheter, ureteral | 367 | 310 | $12K |
| 99152 | 174 | 154 | $12K | |
| 84100 | 3,121 | 1,857 | $12K | |
| 87205 | 3,272 | 2,719 | $12K | |
| 86618 | 698 | 612 | $11K | |
| 80081 | 132 | 129 | $11K | |
| 83020 | 978 | 912 | $11K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 22,915 | 18,667 | $11K |
| 36600 | 328 | 290 | $11K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 9,604 | 8,469 | $11K |
| 86592 | 2,450 | 2,178 | $11K | |
| 84153 | 697 | 638 | $10K | |
| 85652 | 4,469 | 3,802 | $10K | |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 76 | 67 | $10K |
| 86757 | 307 | 267 | $10K | |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | 1,520 | 1,180 | $10K |
| 80076 | 1,334 | 1,129 | $10K | |
| 86334 | 507 | 468 | $9K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 1,778 | 1,522 | $9K |
| A9541 | Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | 99 | 91 | $9K |
| J0690 | Injection, cefazolin sodium, 500 mg | 2,063 | 1,559 | $9K |
| 82103 | 745 | 629 | $9K | |
| 93798 | 332 | 60 | $9K | |
| 86431 | 1,809 | 1,639 | $9K | |
| 83655 | 774 | 741 | $9K | |
| 82565 | 881 | 541 | $9K | |
| 82105 | 582 | 540 | $9K | |
| 84156 | 2,765 | 2,245 | $9K | |
| 86200 | 760 | 690 | $8K | |
| 82627 | 438 | 358 | $8K | |
| 83630 | 485 | 401 | $8K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 560 | 273 | $8K |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 1,480 | 1,385 | $8K |
| 96523 | 307 | 251 | $8K | |
| 82950 | 1,724 | 1,628 | $8K | |
| 86381 | 415 | 385 | $8K | |
| J0688 | Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg | 706 | 609 | $8K |
| 82150 | 1,422 | 1,234 | $8K | |
| 99153 | Mod sedat endo service >5yrs | 57 | 52 | $8K |
| 94010 | 112 | 104 | $8K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 117 | 112 | $8K |
| 73552 | 72 | 66 | $8K | |
| 80069 | 1,024 | 708 | $8K | |
| 83525 | 835 | 755 | $8K | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 2,242 | 1,648 | $8K |
| 64415 | 16 | 12 | $8K | |
| 84550 | 1,971 | 1,771 | $8K | |
| 86364 | 600 | 567 | $7K | |
| 94761 | 567 | 344 | $7K | |
| 84436 | 1,304 | 1,160 | $7K | |
| 49083 | 25 | 12 | $7K | |
| 74230 | 67 | 43 | $7K | |
| A9537 | Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries | 174 | 158 | $7K |
| 86762 | 532 | 490 | $7K | |
| 77002 | 37 | 36 | $7K | |
| 86664 | 510 | 481 | $7K | |
| 0012A | 269 | 264 | $6K | |
| 86800 | 513 | 480 | $6K | |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | 19 | 19 | $6K |
| 93923 | 71 | 66 | $6K | |
| 82670 | 268 | 225 | $6K | |
| 88302 | 402 | 205 | $6K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 1,555 | 753 | $6K |
| 82947 | 1,653 | 1,038 | $6K | |
| 88300 | 403 | 354 | $6K | |
| 82375 | 488 | 368 | $6K | |
| 83516 | 550 | 279 | $6K | |
| 31624 | 28 | 12 | $6K | |
| 43249 | 52 | 24 | $6K | |
| 81002 | 1,162 | 982 | $6K | |
| J1790 | Injection, droperidol, up to 5 mg | 817 | 769 | $6K |
| J1453 | Injection, fosaprepitant, 1 mg | 117 | 78 | $6K |
| 72114 | 28 | 25 | $5K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 690 | 608 | $5K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 279 | 235 | $5K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 9,181 | 7,929 | $5K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 278 | 251 | $5K |
| J2791 | Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu | 118 | 105 | $5K |
| 93225 | 63 | 57 | $5K | |
| 84144 | 303 | 271 | $5K | |
| 88312 | 118 | 77 | $5K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 1,182 | 520 | $5K |
| 88341 | 43 | 36 | $5K | |
| 93970 | 34 | 30 | $5K | |
| 87071 | 661 | 474 | $5K | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 395 | 338 | $5K |
| 82803 | 204 | 184 | $5K | |
| 84145 | 229 | 183 | $5K | |
| 29580 | 59 | 25 | $4K | |
| 73070 | 32 | 25 | $4K | |
| J1644 | Injection, heparin sodium, per 1000 units | 1,696 | 952 | $4K |
| 95909 | 12 | 12 | $4K | |
| 86706 | 525 | 470 | $4K | |
| 72158 | 19 | 13 | $4K | |
| 73060 | 72 | 65 | $4K | |
| 97116 | 274 | 160 | $4K | |
| 0011A | 243 | 235 | $4K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 2,349 | 1,822 | $4K |
| 84479 | 826 | 741 | $4K | |
| 82140 | 320 | 258 | $4K | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 4,245 | 2,151 | $4K |
| 86008 | 382 | 361 | $4K | |
| 86015 | 391 | 363 | $4K | |
| 86256 | 179 | 148 | $4K | |
| 86704 | 381 | 328 | $4K | |
| A4648 | Tissue marker, implantable, any type, each | 85 | 37 | $4K |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 480 | 315 | $3K |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 1,160 | 1,040 | $3K |
| 95819 | 37 | 32 | $3K | |
| 86308 | 761 | 723 | $3K | |
| G0148 | Screening cytopathology smears, cervical or vaginal, performed by automated system with manual rescreening | 136 | 127 | $3K |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | 1,964 | 1,755 | $3K |
| 97802 | 250 | 236 | $3K | |
| 82533 | 226 | 200 | $3K | |
| 85014 | 735 | 399 | $3K | |
| 82672 | 169 | 160 | $3K | |
| 82390 | 350 | 329 | $3K | |
| 82248 | 826 | 596 | $3K | |
| 88108 | 133 | 81 | $3K | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 687 | 580 | $3K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 4,265 | 3,485 | $3K |
| 86701 | 384 | 320 | $3K | |
| 31500 | 29 | 24 | $3K | |
| 87902 | 14 | 12 | $3K | |
| 83050 | 389 | 337 | $3K | |
| Q9968 | Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg | 112 | 62 | $3K |
| P9612 | Catheterization for collection of specimen, single patient, all places of service | 607 | 347 | $3K |
| 87529 | 43 | 41 | $3K | |
| 92523 | 27 | 27 | $3K | |
| 86923 | 56 | 36 | $3K | |
| J2060 | Injection, lorazepam, 2 mg | 1,769 | 1,434 | $3K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 2,808 | 2,500 | $3K |
| 94618 | 54 | 45 | $3K | |
| 82009 | 669 | 584 | $2K | |
| 93325 | 13 | 13 | $2K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | 334 | 207 | $2K |
| 86231 | 247 | 235 | $2K | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 402 | 320 | $2K |
| 83498 | 98 | 80 | $2K | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 153 | 131 | $2K |
| 82652 | 83 | 64 | $2K | |
| 92609 | 32 | 12 | $2K | |
| 97022 | 377 | 70 | $2K | |
| 84165 | 201 | 191 | $2K | |
| 86666 | 62 | 56 | $2K | |
| 83615 | 307 | 284 | $2K | |
| 80164 | 159 | 141 | $2K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 544 | 349 | $2K |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 340 | 282 | $2K |
| 73523 | 16 | 14 | $2K | |
| J3370 | Injection, vancomycin hcl, 500 mg | 198 | 108 | $2K |
| 70360 | 14 | 14 | $2K | |
| J1956 | Injection, levofloxacin, 250 mg | 662 | 571 | $1K |
| 82820 | 162 | 136 | $1K | |
| 86258 | 117 | 110 | $1K | |
| 82977 | 233 | 201 | $1K | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 108 | 93 | $1K |
| 87899 | 248 | 94 | $1K | |
| 73620 | 16 | 13 | $1K | |
| 82951 | 123 | 115 | $1K | |
| 83921 | 64 | 61 | $1K | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 466 | 403 | $1K |
| 92610 | 15 | 13 | $1K | |
| 94664 | 46 | 26 | $1K | |
| 85018 | 437 | 307 | $1K | |
| 82365 | 79 | 71 | $1K | |
| 86769 | 60 | 30 | $1K | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 111 | 29 | $1K |
| J1940 | Injection, furosemide, up to 20 mg | 298 | 188 | $969.49 |
| 85045 | 281 | 262 | $914.43 | |
| 87449 | 126 | 96 | $908.08 | |
| 84460 | 187 | 173 | $906.79 | |
| 87484 | 27 | 27 | $871.66 | |
| J3480 | Injection, potassium chloride, per 2 meq | 86 | 53 | $834.84 |
| 64450 | 16 | 14 | $828.93 | |
| 87045 | 111 | 85 | $812.25 | |
| 87593 | 12 | 12 | $796.07 | |
| 0004A | 22 | 22 | $784.48 | |
| 87116 | 88 | 51 | $766.80 | |
| 88173 | 23 | 14 | $750.76 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 192 | 167 | $739.90 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 144 | 123 | $724.67 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 512 | 467 | $724.53 |
| 86060 | 130 | 120 | $722.56 | |
| 86694 | 58 | 47 | $718.54 | |
| 87046 | 111 | 85 | $714.10 | |
| 97162 | 13 | 13 | $710.06 | |
| 85007 | 279 | 225 | $682.99 | |
| 97014 | 41 | 13 | $666.16 | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 37 | 33 | $656.90 |
| 82247 | 192 | 115 | $655.40 | |
| 86663 | 48 | 45 | $640.20 | |
| J3411 | Injection, thiamine hcl, 100 mg | 120 | 91 | $613.17 |
| 97010 | 373 | 124 | $610.83 | |
| 83883 | 31 | 28 | $610.18 | |
| 86141 | 73 | 55 | $603.49 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 725 | 659 | $595.24 |
| 80178 | 100 | 87 | $588.36 | |
| 82330 | 53 | 50 | $587.96 | |
| 0031A | 24 | 23 | $567.04 | |
| 84410 | 13 | 12 | $564.08 | |
| 84480 | 66 | 51 | $558.68 | |
| 87350 | 74 | 57 | $552.29 | |
| G0475 | Hiv antigen/antibody, combination assay, screening | 25 | 24 | $545.48 |
| 82175 | 20 | 14 | $541.46 | |
| 84450 | 115 | 104 | $535.15 | |
| 86707 | 70 | 55 | $531.06 | |
| 82040 | 42 | 40 | $515.26 | |
| 86255 | 66 | 40 | $482.00 | |
| 82378 | 33 | 25 | $474.00 | |
| 86705 | 69 | 54 | $457.85 | |
| 83014 | 82 | 69 | $433.11 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 26 | 16 | $416.68 |
| 94760 | 57 | 39 | $409.60 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 116 | 95 | $384.24 |
| 82104 | 28 | 28 | $349.50 | |
| 87102 | 46 | 27 | $344.81 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 316 | 283 | $338.50 |
| 86403 | 34 | 29 | $337.52 | |
| 97012 | 46 | 13 | $336.12 | |
| 86063 | 87 | 77 | $326.07 | |
| 87338 | 28 | 24 | $317.58 | |
| 82525 | 28 | 27 | $297.84 | |
| 82952 | 93 | 86 | $288.89 | |
| 82397 | 13 | 13 | $280.29 | |
| 84681 | 13 | 13 | $270.53 | |
| 83721 | 87 | 80 | $260.48 | |
| 89051 | 56 | 45 | $257.60 | |
| 86160 | 12 | 12 | $256.08 | |
| 36416 | 63 | 39 | $221.30 | |
| 83993 | 12 | 12 | $217.98 | |
| J1953 | Injection, levetiracetam, 10 mg | 29 | 26 | $215.50 |
| 87206 | 51 | 27 | $204.82 | |
| 86645 | 12 | 12 | $199.67 | |
| 84520 | 54 | 45 | $196.09 | |
| 86644 | 12 | 12 | $170.52 | |
| 87328 | 19 | 13 | $164.46 | |
| 82310 | 19 | 12 | $159.51 | |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 72 | 71 | $157.36 |
| 83010 | 12 | 12 | $149.07 | |
| 87329 | 19 | 13 | $142.56 | |
| C9113 | Injection, pantoprazole sodium, per vial | 53 | 39 | $140.05 |
| 83527 | 12 | 12 | $129.50 | |
| J0736 | Injection, clindamycin phosphate, 300 mg | 19 | 12 | $106.19 |
| J1630 | Injection, haloperidol, up to 5 mg | 68 | 68 | $101.92 |
| 86593 | 26 | 24 | $96.80 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 88 | 74 | $87.51 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 14 | 13 | $77.56 |
| J0592 | Injection, buprenorphine hydrochloride, 0.1 mg | 12 | 12 | $70.11 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 199 | 175 | $65.70 |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | 30 | 25 | $63.60 |
| 81050 | 13 | 12 | $50.99 | |
| J0456 | Injection, azithromycin, 500 mg | 12 | 12 | $30.15 |
| 84155 | 13 | 12 | $29.36 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 86 | 79 | $16.28 |